1 year return (CAGR)
-
Maze Therapeutics, Inc. Common Stock Exchange (NASDAQ, USD)
MAZE
24.67
+0.07 (+0.28%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-
5 year return (CAGR)
-
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
1.37B
Price/Sales
68.52
Ent value
1.25B
Price/Book
3.02
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 24.90 |
| Daily high | 25.85 |
| Daily low | 24.46 |
| Daily Volume | 589K |
| All-time high | 51.84 |
| 1y analyst estimate | 62.55 |
| Beta | - |
| EPS (TTM) | -2.26 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| MAZE | S&P500 | |
| Current price drop from All-time high | -52.41% | -2.19% |
| Highest price drop | -54.51% | -56.47% |
| Date of highest drop | 8 Jun 2026 | 9 Mar 2009 |
| Avg drop from high | -24.74% | -10.68% |
| Avg time to new high | 7 days | 12 days |
| Max time to new high | 128 days | 1805 days |
News
